62
Participants
Start Date
December 7, 2020
Primary Completion Date
September 15, 2021
Study Completion Date
September 15, 2021
Restylane Defyne
Up to 2 milliliters (ml) of Restylane Defyne per treatment site (chin and surrounding area) with maximum of total 4 ml at baseline, up to 2 ml of Restylane Defyne per NLF and ML at week 3 and optional up to 2 ml of Restylane Defyne per facial half for NLF and ML in combination with a total of 2 ml in the chin and surrounding area at week 6.
Restylane Defyne
Up to 2 ml of Restylane Defyne per NLF and ML at baseline, up to 2 ml of Restylane Defyne per treatment site (chin and surrounding area) with maximum of total 4 ml at week 3 and optional touch-up of up to 2 ml per facial half for NLF and ML in combination with a total of 2 ml in the chin and surrounding area at week 6.
Galderma Research Site, Birmingham
Galderma Research Site, Chicago
Galderma Research Site, Belo Horizonte
Galderma Research Site, São Paulo
Galderma Research Site, Palermo
Lead Sponsor
Galderma R&D
INDUSTRY